This is particularly relevant as Gram-negative bacteria, including enterobacteria, are major LPS producers, and their reduction may lower susceptibility to colitis and attenuate inflammatory responses mediated by proinflammatory cytokines such as TNF-α and IL-1β [34,35]. The gene discussed is IL1B; the disease is colitis.